50 Healthcare Stocks Moving In Thursday's After-Market Session

Loading...
Loading...

Gainers

  • Guardion Health Sciences, Inc. GHSI shares surged 25.0% to $0.70 during Thursday's after-market session. The market cap stands at $23.8 million.
  • Vaxart, Inc. VXRT shares rose 23.9% to $0.72. The market value of their outstanding shares is at $10.8 million. The most recent rating by H.C. Wainwright, on June 27, is at Buy, with a price target of $2.00.
  • Puma Biotechnology, Inc. PBYI shares moved upwards by 23.2% to $11.35. The market cap stands at $337.8 million.
  • Eidos Therapeutics, Inc. EIDX stock rose 15.4% to $36.99. The market value of their outstanding shares is at $728.4 million. The most recent rating by Piper Jaffray, on July 22, is at Overweight, with a price target of $55.00.
  • ENDRA Life Sciences, Inc. NDRA shares rose 12.7% to $1.60. The market cap seems to be at $9.9 million. The most recent rating by H.C. Wainwright, on July 15, is at Buy, with a price target of $6.00.
  • Kitov Pharma, Inc. KTOV shares surged 12.1% to $0.83. The market cap stands at $15.8 million.
  • Lexicon Pharmaceuticals, Inc. LXRX shares surged 11.7% to $1.43. The market cap stands at $1.1 billion. The most recent rating by Citigroup, on July 30, is at Buy, with a price target of $3.00.
  • Sensus Healthcare, Inc. SRTS stock surged 11.6% to $5.99. The market value of their outstanding shares is at $83.9 million.
  • Sientra, Inc. SIEN shares surged 11.4% to $5.56. The market value of their outstanding shares is at $251.9 million. The most recent rating by Wells Fargo, on June 05, is at Outperform, with a price target of $10.00.
  • TherapeuticsMD, Inc. TXMD shares increased by 9.1% to $2.88. The market cap stands at $1.0 million.
  • Sesen Bio, Inc. SESN shares rose 8.6% to $1.27. The market value of their outstanding shares is at $92.8 million. The most recent rating by H.C. Wainwright, on June 11, is at Buy, with a price target of $3.00.
  • Omeros, Inc. OMER shares moved upwards by 7.3% to $17.50. The market cap stands at $986.1 million.
  • Marker Therapeutics, Inc. MRKR shares surged 6.7% to $4.76. The market value of their outstanding shares is at $186.4 million. The most recent rating by Oppenheimer, on July 03, is at Outperform, with a price target of $15.00.
  • Opiant Pharmaceuticals, Inc. OPNT shares moved upwards by 6.2% to $13.70. The market value of their outstanding shares is at $47.6 million.
  • Brainstorm Cell, Inc. BCLI shares rose 6.1% to $4.18.
  • Clovis Oncology, Inc. CLVS stock increased by 5.2% to $6.13. According to the most recent rating by Guggenheim, on August 02, the current rating is at Neutral.
  • Cellectar Biosciences, Inc. CLRB stock rose 4.6% to $2.29. The market cap stands at $19.7 million. The most recent rating by Brookline Capital, on July 30, is at Buy, with a price target of $6.00.
  • Community Health Systems, Inc. CYH stock moved upwards by 4.4% to $2.37.
  • Innovate, Inc. INNT shares rose 4.1% to $0.98. The market cap seems to be at $32.9 million.
  • Nabriva Therapeutics, Inc. NBRV shares surged 4.0% to $2.37. The market value of their outstanding shares is at $166.5 million.
  • Co-Diagnostics, Inc. CODX stock increased by 3.9% to $1.33. The market cap stands at $21.7 million.
  • Livongo Health, Inc. LVGO stock moved upwards by 3.9% to $34.50. The market cap seems to be at $3.0 billion.
  • Immunogen, Inc. IMGN stock surged 3.5% to $2.94. The market cap stands at $1.4 billion.
  • ADMA Biologics, Inc. ADMA shares rose 3.2% to $3.58. The market cap seems to be at $193.3 million. The most recent rating by Jefferies, on June 04, is at Buy, with a price target of $8.00.
  • Evoke Pharma, Inc. EVOK stock moved upwards by 3.0% to $0.93. The market cap stands at $20.4 million.

 

Losers

  • ViewRay, Inc. VRAY stock fell 48.8% to $3.45 during Thursday's after-market session. The market cap seems to be at $718.4 million. The most recent rating by Piper Jaffray, on June 18, is at Overweight, with a price target of $15.00.
  • Nektar Therapeutics, Inc. NKTR stock declined 29.4% to $20.88. The market cap stands at $4.9 billion. The most recent rating by Mizuho, on July 26, is at Buy, with a price target of $79.00.
  • Amarin Corp, Inc. AMRN shares fell 23.6% to $13.60. The market cap stands at $6.0 billion.
  • Adamas Pharmaceuticals, Inc. ADMS stock fell 19.6% to $4.92. The market cap stands at $165.1 million.
  • Kala Pharmaceuticals, Inc. KALA shares fell 13.0% to $4.00. The most recent rating by H.C. Wainwright, on August 07, is at Buy, with a price target of $12.00.
  • Vermillion, Inc. VRML shares fell 12.8% to $0.55. The market cap stands at $64.1 million.
  • Intrexon, Inc. XON shares decreased by 11.4% to $6.75. The market cap stands at $1.8 billion.
  • Acasti Pharma, Inc. ACST shares decreased by 10.5% to $2.05. The market cap seems to be at $57.6 million. The most recent rating by Oppenheimer, on July 18, is at Outperform, with a price target of $7.00.
  • Hoth Therapeutics, Inc. HOTH shares decreased by 8.4% to $4.89. The market cap seems to be at $53.5 million. According to the most recent rating by Laidlaw & Co., on May 20, the current rating is at Buy.
  • Fate Therapeutics, Inc. FATE stock decreased by 7.3% to $17.85. The market value of their outstanding shares is at $476.7 million. The most recent rating by Cantor Fitzgerald, on July 22, is at Overweight, with a price target of $32.00.
  • Viveve Medical, Inc. VIVE shares plummeted 6.8% to $0.15. The market cap stands at $7.2 million. According to the most recent rating by Ladenburg Thalmann, on July 24, the current rating is at Neutral.
  • ReWalk Robotics, Inc. RWLK shares plummeted 6.3% to $3.25. The market value of their outstanding shares is at $22.3 million. The most recent rating by H.C. Wainwright, on June 17, is at Buy, with a price target of $9.00.
  • Valeritas Holdings, Inc. VLRX stock declined 6.1% to $2.75. The market cap stands at $15.0 million.
  • Syndax Pharmaceuticals, Inc. SNDX stock declined 6.0% to $9.50. The market cap seems to be at $238.1 million.
  • Affimed, Inc. AFMD stock decreased by 5.0% to $2.63. The market value of their outstanding shares is at $102.9 million.
  • Accelerate Diagnostics, Inc. AXDX shares fell 5.0% to $15.79. The market cap stands at $1.2 billion.
  • TrovaGene, Inc. TROV stock declined 4.2% to $1.60. The market cap stands at $8.6 million.
  • Aclaris Therapeutics, Inc. ACRS stock decreased by 4.0% to $0.95. The market value of their outstanding shares is at $530.7 million. According to the most recent rating by SVB Leerink, on June 27, the current rating is at Market Perform.
  • Inovio Pharmaceuticals, Inc. INO shares decreased by 3.5% to $2.45. The market cap stands at $266.6 million.
  • Tetraphase Pharmaceutical, Inc. TTPH shares declined 3.4% to $0.33. The market cap seems to be at $187.1 million.
  • Minerva Neurosciences, Inc. NERV stock declined 3.4% to $6.80. The market value of their outstanding shares is at $272.0 million. The most recent rating by H.C. Wainwright, on May 31, is at Buy, with a price target of $22.00.
  • Global Blood Therapeutics, Inc. GBT shares declined 3.2% to $48.00. The market cap stands at $2.9 billion. The most recent rating by Goldman Sachs, on May 29, is at Neutral, with a price target of $75.00.
  • Cardinal Health, Inc. CAH shares plummeted 3.1% to $42.52. The market cap seems to be at $19.7 billion.
  • Abiomed, Inc. ABMD shares plummeted 3.0% to $186.00. The market cap stands at $18.1 billion. The most recent rating by Morgan Stanley, on August 02, is at Equal-Weight, with a price target of $215.00.
  • G1 Therapeutics, Inc. GTHX stock decreased by 3.0% to $28.88. The market cap stands at $690.5 million. The most recent rating by JP Morgan, on August 08, is at Overweight, with a price target of $45.00.
Loading...
Loading...
Posted In: NewsMovers & ShakersAfter-Hours CenterMarketsMoversTrading IdeasGeneralBiotechnologyHealth CareHealthcare Stocks After-Market MoversTop Gainers
We simplify the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...